AI assistant
Sending…
MKS INC — Director's Dealing 2013
Mar 4, 2013
30723_dirs_2013-03-04_f2f56c26-f51c-4d6d-b5b3-9df89802d043.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MKS INSTRUMENTS INC (MKSI)
CIK: 0001049502
Period of Report: 2013-02-28
Reporting Person: COLELLA GERARD G (President, COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-28 | Common Stock | M | 3941.817 | — | Acquired | 3965.492 | Direct |
| 2013-02-28 | Common Stock | M | 2776 | — | Acquired | 6741.492 | Direct |
| 2013-02-28 | Common Stock | F | 2191 | $27.14 | Disposed | 4550.492 | Direct |
| 2013-03-01 | Common Stock | S | 4525 | $27.00 | Disposed | 25.492 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-28 | Restricted Stock Unit | $ | M | 3941.817 | Disposed | Common Stock (3941.817) | Direct | |
| 2013-02-28 | Restricted Stock Unit | $ | M | 2776 | Disposed | Common Stock (2776) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of common stock of MKS Instruments, Inc.
F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F3: These RSUs are subject to the achievement of performance criteria determined in the first year of the grant and thereafter vests in equal annual installments over three years.
F4: The RSUs vest in equal annual installments over three years.
More from MKS INC
Regulatory Filings
2026
May 28
Share Issue/Capital Change
2026
May 11
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 6
Board/Management Information
2026
Apr 6
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3